These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 15095370

  • 1. Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure.
    Barcia C, Sánchez Bahillo A, Fernández-Villalba E, Bautista V, Poza Y Poza M, Fernández-Barreiro A, Hirsch EC, Herrero MT.
    Glia; 2004 May; 46(4):402-9. PubMed ID: 15095370
    [Abstract] [Full Text] [Related]

  • 2. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
    Muramatsu Y, Kurosaki R, Watanabe H, Michimata M, Matsubara M, Imai Y, Araki T.
    Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835
    [Abstract] [Full Text] [Related]

  • 3. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L, Garris BL, Garris DR, Lau YS.
    Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572
    [Abstract] [Full Text] [Related]

  • 4. Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Yasuda Y, Shinagawa R, Yamada M, Mori T, Tateishi N, Fujita S.
    Brain Res; 2007 Mar 23; 1138():196-202. PubMed ID: 17275793
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Sugama S, Wirz SA, Barr AM, Conti B, Bartfai T, Shibasaki T.
    Neuroscience; 2004 Mar 23; 128(2):451-8. PubMed ID: 15350655
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acute and chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrations elicit similar microglial activation in the substantia nigra of monkeys.
    Vázquez-Claverie M, Garrido-Gil P, San Sebastián W, Izal-Azcárate A, Belzunegui S, Marcilla I, López B, Luquin MR.
    J Neuropathol Exp Neurol; 2009 Sep 23; 68(9):977-84. PubMed ID: 19680145
    [Abstract] [Full Text] [Related]

  • 9. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.
    Kim S, Moon M, Park S.
    J Endocrinol; 2009 Sep 23; 202(3):431-9. PubMed ID: 19570816
    [Abstract] [Full Text] [Related]

  • 10. The 6-hydroxydopamine-induced nigrostriatal neurodegeneration produces microglia-like NG2 glial cells in the rat substantia nigra.
    Kitamura Y, Inden M, Minamino H, Abe M, Takata K, Taniguchi T.
    Glia; 2010 Nov 01; 58(14):1686-700. PubMed ID: 20629191
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration.
    Holmer HK, Keyghobadi M, Moore C, Menashe RA, Meshul CK.
    Synapse; 2005 Aug 01; 57(2):100-12. PubMed ID: 15906381
    [Abstract] [Full Text] [Related]

  • 13. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sawada H, Hishida R, Hirata Y, Ono K, Suzuki H, Muramatsu S, Nakano I, Nagatsu T, Sawada M.
    J Neurosci Res; 2007 Jun 01; 85(8):1752-61. PubMed ID: 17469135
    [Abstract] [Full Text] [Related]

  • 14. Acupuncture inhibits microglial activation and inflammatory events in the MPTP-induced mouse model.
    Kang JM, Park HJ, Choi YG, Choe IH, Park JH, Kim YS, Lim S.
    Brain Res; 2007 Feb 02; 1131(1):211-9. PubMed ID: 17173870
    [Abstract] [Full Text] [Related]

  • 15. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure fails to produce delayed degeneration of substantia nigra neurons in monkeys.
    Garrido-Gil P, Belzunegui S, San Sebastián W, Izal-Azcárate A, López B, Marcilla I, Luquin MR.
    J Neurosci Res; 2009 Feb 02; 87(2):586-97. PubMed ID: 18798285
    [Abstract] [Full Text] [Related]

  • 16. Cellular distribution of interleukin-1alpha-immunoreactivity after MPTP intoxication in mice.
    Hébert G, Mingam R, Arsaut J, Dantzer R, Demotes-Mainard J.
    Brain Res Mol Brain Res; 2005 Aug 18; 138(2):156-63. PubMed ID: 15922486
    [Abstract] [Full Text] [Related]

  • 17. Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice.
    Ohashi S, Mori A, Kurihara N, Mitsumoto Y, Nakai M.
    Neurosci Lett; 2006 Jun 19; 401(1-2):183-7. PubMed ID: 16581184
    [Abstract] [Full Text] [Related]

  • 18. Pathogenic role of glial cells in Parkinson's disease.
    Teismann P, Tieu K, Cohen O, Choi DK, Wu DC, Marks D, Vila M, Jackson-Lewis V, Przedborski S.
    Mov Disord; 2003 Feb 19; 18(2):121-9. PubMed ID: 12539204
    [Abstract] [Full Text] [Related]

  • 19. Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication.
    Rolland AS, Tandé D, Herrero MT, Luquin MR, Vazquez-Claverie M, Karachi C, Hirsch EC, François C.
    J Neurochem; 2009 Aug 19; 110(4):1321-9. PubMed ID: 19527435
    [Abstract] [Full Text] [Related]

  • 20. Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning.
    Guigoni C, Dovero S, Aubert I, Li Q, Bioulac BH, Bloch B, Gurevich EV, Gross CE, Bezard E.
    Eur J Neurosci; 2005 Jul 19; 22(1):283-7. PubMed ID: 16029219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.